RPS6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.889400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.099200E-01
Normal-vs-Stage2
2.828400E-01
Normal-vs-Stage3
2.810400E-01
Normal-vs-Stage4
7.530600E-01
Stage1-vs-Stage2
1.508970E-01
Stage1-vs-Stage3
8.538400E-01
Stage1-vs-Stage4
1.362630E-01
Stage2-vs-Stage3
5.653000E-01
Stage2-vs-Stage4
7.937700E-02
Stage3-vs-Stage4
1.487230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.009800E-01
Normal-vs-AfricanAmerican
2.910800E-01
Normal-vs-Asian
7.877800E-01
Caucasian-vs-AfricanAmerican
9.640800E-01
Caucasian-vs-Asian
7.705200E-01
AfricanAmerican-vs-Asian
7.953000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.376000E-01
Normal-vs-Female
8.459800E-02
Male-vs-Female
2.496000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.891030E-01
Normal-vs-Age(41-60Yrs)
9.364400E-02
Normal-vs-Age(61-80Yrs)
4.148000E-01
Normal-vs-Age(81-100Yrs)
2.556800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.546000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.581800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.536000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.133400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.453400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.582000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.726100E-02
Normal-vs-Daily Drinker
5.993800E-02
Normal-vs-Weekly Drinker
9.202600E-01
Normal-vs-Occasional Drinker
1.774190E-01
Normal-vs-Social Drinker
1.498440E-01
Non Drinker-vs-Daily Drinker
8.003800E-01
Non Drinker-vs-Weekly Drinker
2.521400E-01
Non Drinker-vs-Occasional Drinker
2.994800E-01
Non Drinker-vs-Social Drinker
5.249000E-01
Daily Drinker-vs-Weekly Drinker
2.282000E-01
Daily Drinker-vs-Occasional Drinker
2.534000E-01
Daily Drinker-vs-Social Drinker
4.391200E-01
Weekly Drinker-vs-Occasional Drinker
4.170000E-01
Weekly Drinker-vs-Social Drinker
3.575600E-01
Occasional Drinker-vs-Social Drinker
7.624200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.610600E-01
Normal-vs-Grade 2
7.458800E-01
Normal-vs-Grade 3
8.345000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.578000E-01
Grade 1-vs-Grade 3
8.839200E-01
Grade 1-vs-Grade 4
8.610600E-01
Grade 2-vs-Grade 3
9.179200E-01
Grade 2-vs-Grade 4
7.458800E-01
Grade 3-vs-Grade 4
8.345000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.197400E-01
Normal-vs-NonDiabetic
2.235400E-01
Diabetic-vs-NonDiabetic
2.060600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.315400E-01
Normal-vs-NoPancreatitis
3.641800E-01
Pancreatitis-vs-NoPancreatitis
2.441500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.740600E-01
Normal-vs-N1
2.124800E-01
N0-vs-N1
7.977900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.449400E-01
Normal-vs-TP53-NonMutant
6.390200E-01
TP53-Mutant-vs-TP53-NonMutant
7.310500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
